369 related articles for article (PubMed ID: 32051275)
1. Modified Sialic Acids on Mucus and Erythrocytes Inhibit Influenza A Virus Hemagglutinin and Neuraminidase Functions.
Barnard KN; Alford-Lawrence BK; Buchholz DW; Wasik BR; LaClair JR; Yu H; Honce R; Ruhl S; Pajic P; Daugherity EK; Chen X; Schultz-Cherry SL; Aguilar HC; Varki A; Parrish CR
J Virol; 2020 Apr; 94(9):. PubMed ID: 32051275
[TBL] [Abstract][Full Text] [Related]
2. Expression of 9-
Barnard KN; Wasik BR; LaClair JR; Buchholz DW; Weichert WS; Alford-Lawrence BK; Aguilar HC; Parrish CR
mBio; 2019 Dec; 10(6):. PubMed ID: 31796537
[TBL] [Abstract][Full Text] [Related]
3. Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase.
Cohen M; Zhang XQ; Senaati HP; Chen HW; Varki NM; Schooley RT; Gagneux P
Virol J; 2013 Nov; 10():321. PubMed ID: 24261589
[TBL] [Abstract][Full Text] [Related]
4. Distribution of O-Acetylated Sialic Acids among Target Host Tissues for Influenza Virus.
Wasik BR; Barnard KN; Ossiboff RJ; Khedri Z; Feng KH; Yu H; Chen X; Perez DR; Varki A; Parrish CR
mSphere; 2017; 2(5):. PubMed ID: 28904995
[TBL] [Abstract][Full Text] [Related]
5. Substrate Binding by the Second Sialic Acid-Binding Site of Influenza A Virus N1 Neuraminidase Contributes to Enzymatic Activity.
Du W; Dai M; Li Z; Boons GJ; Peeters B; van Kuppeveld FJM; de Vries E; de Haan CAM
J Virol; 2018 Oct; 92(20):. PubMed ID: 30089692
[TBL] [Abstract][Full Text] [Related]
6. Role of Neuraminidase in Influenza A(H7N9) Virus Receptor Binding.
Benton DJ; Wharton SA; Martin SR; McCauley JW
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356530
[TBL] [Abstract][Full Text] [Related]
7. Second sialic acid-binding site of influenza A virus neuraminidase: binding receptors for efficient release.
Du W; de Vries E; van Kuppeveld FJM; Matrosovich M; de Haan CAM
FEBS J; 2021 Oct; 288(19):5598-5612. PubMed ID: 33314755
[TBL] [Abstract][Full Text] [Related]
8. Kinetic analysis of the influenza A virus HA/NA balance reveals contribution of NA to virus-receptor binding and NA-dependent rolling on receptor-containing surfaces.
Guo H; Rabouw H; Slomp A; Dai M; van der Vegt F; van Lent JWM; McBride R; Paulson JC; de Groot RJ; van Kuppeveld FJM; de Vries E; de Haan CAM
PLoS Pathog; 2018 Aug; 14(8):e1007233. PubMed ID: 30102740
[TBL] [Abstract][Full Text] [Related]
9. Sequence dynamics of three influenza A virus strains grown in different MDCK cell lines, including those expressing different sialic acid receptors.
Barnard KN; Wasik BR; Alford BK; Hayward JJ; Weichert WS; Voorhees IEH; Holmes EC; Parrish CR
J Evol Biol; 2021 Dec; 34(12):1878-1900. PubMed ID: 34114711
[TBL] [Abstract][Full Text] [Related]
10. Single Particle Analysis of H3N2 Influenza Entry Differentiates the Impact of the Sialic Acids (Neu5Ac and Neu5Gc) on Virus Binding and Membrane Fusion.
Chien YA; Alford BK; Wasik BR; Weichert WS; Parrish CR; Daniel S
J Virol; 2023 Mar; 97(3):e0146322. PubMed ID: 36779754
[TBL] [Abstract][Full Text] [Related]
11. The 2nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin-neuraminidase-receptor balance.
Du W; Guo H; Nijman VS; Doedt J; van der Vries E; van der Lee J; Li Z; Boons GJ; van Kuppeveld FJM; de Vries E; Matrosovich M; de Haan CAM
PLoS Pathog; 2019 Jun; 15(6):e1007860. PubMed ID: 31181126
[TBL] [Abstract][Full Text] [Related]
12. Sialylated and sulfated N-Glycans in MDCK and engineered MDCK cells for influenza virus studies.
Byrd-Leotis L; Jia N; Matsumoto Y; Lu D; Kawaoka Y; Steinhauer DA; Cummings RD
Sci Rep; 2022 Jul; 12(1):12757. PubMed ID: 35882911
[TBL] [Abstract][Full Text] [Related]
13. Mutation of the Second Sialic Acid-Binding Site, Resulting in Reduced Neuraminidase Activity, Preceded the Emergence of H7N9 Influenza A Virus.
Dai M; McBride R; Dortmans JCFM; Peng W; Bakkers MJG; de Groot RJ; van Kuppeveld FJM; Paulson JC; de Vries E; de Haan CAM
J Virol; 2017 May; 91(9):. PubMed ID: 28202753
[TBL] [Abstract][Full Text] [Related]
14. Influenza A Virus Hemagglutinin-Neuraminidase-Receptor Balance: Preserving Virus Motility.
de Vries E; Du W; Guo H; de Haan CAM
Trends Microbiol; 2020 Jan; 28(1):57-67. PubMed ID: 31629602
[TBL] [Abstract][Full Text] [Related]
15. Influenza A virus diffusion through mucus gel networks.
Kaler L; Iverson E; Bader S; Song D; Scull MA; Duncan GA
Commun Biol; 2022 Mar; 5(1):249. PubMed ID: 35318436
[TBL] [Abstract][Full Text] [Related]
16. Neuraminidase activity and specificity of influenza A virus are influenced by haemagglutinin-receptor binding.
Lai JCC; Karunarathna HMTK; Wong HH; Peiris JSM; Nicholls JM
Emerg Microbes Infect; 2019; 8(1):327-338. PubMed ID: 30866786
[TBL] [Abstract][Full Text] [Related]
17. Influenza A virus hemagglutinin and neuraminidase act as novel motile machinery.
Sakai T; Nishimura SI; Naito T; Saito M
Sci Rep; 2017 Mar; 7():45043. PubMed ID: 28344335
[TBL] [Abstract][Full Text] [Related]
18. The avian influenza A virus receptor SA-α2,3-Gal is expressed in the porcine nasal mucosa sustaining the pig as a mixing vessel for new influenza viruses.
Kristensen C; Larsen LE; Trebbien R; Jensen HE
Virus Res; 2024 Feb; 340():199304. PubMed ID: 38142890
[TBL] [Abstract][Full Text] [Related]
19. N-Glycolylneuraminic Acid in Animal Models for Human Influenza A Virus.
Spruit CM; Nemanichvili N; Okamatsu M; Takematsu H; Boons GJ; de Vries RP
Viruses; 2021 May; 13(5):. PubMed ID: 34062844
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting influenza virus transmission using a broadly acting neuraminidase that targets host sialic acids in the upper respiratory tract.
Ortigoza MB; Mobini CL; Rocha HL; Bartlett S; Loomis CA; Weiser JN
mBio; 2024 Feb; 15(2):e0220323. PubMed ID: 38206008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
